{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:39:25Z","timestamp":1794724765972,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Good adherence to antiretroviral therapy is necessary to achieve the best virological response, lower the risk that drug resistance will develop, and reduce morbidity and mortality. Little is known about the rate and predictors of adherence in Ethiopia. Therefore this study determines the magnitude and predictors of adherence to antiretroviral therapy among people living with HIV\/AIDS in Southwest Ethiopia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A cross sectional study was carried out from January 1, 2009 to March 3, 2009 among 319 adult PLWHA (\u2265 18 years) attending ART clinic at Jimma university Specialized Hospital (JUSH). Multiple Logistic regression models were constructed with adherence and independent variables to identify the predictors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>About 303(95%) of the study subjects were adherent based on self report of missed doses (dose adherence) in a one-week recall before the actual interview. The rate of self reported adherence in the study based on the combined indicator of the dose, time and food adherence measurement was 72.4%. Patients who got family support were 2 times [2.12(1.25-3.59)] more likely to adhere than those who didn't get family support as an independent predictor of overall adherence (dose, time and food). The reasons given for missing drugs were 9(27.3%) running out of medication\/drug, 7(21.2%) being away from home and 7(21.2%) being busy with other things.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The adherence rate found in this study is similar to other resource limited setting and higher than the developed country. This study highlights emphasis should be given for income generating activities and social supports that helps to remember the patients for medication taking and management of opportunistic infections during the course of treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-6405-7-39","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T07:32:51Z","timestamp":1288683171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Predictors of adherence to antiretroviral therapy among people living with HIV\/AIDS in resource-limited setting of southwest ethiopia"],"prefix":"10.1186","volume":"7","author":[{"given":"Ayele","family":"Tiyou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tefera","family":"Belachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fisehaye","family":"Alemseged","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibhatu","family":"Biadgilign","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,30]]},"reference":[{"key":"168_CR1","volume-title":"AIDS epidemic update","author":"UNAIDS\/WHO","year":"2009","unstructured":"UNAIDS\/WHO: AIDS epidemic update. 2009, UNAIDS\/09.36E\/JC1700E,"},{"key":"168_CR2","volume-title":"Recommendations for a public health approach","author":"World Health Organization","year":"2006","unstructured":"World Health Organization: Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: Towards universal access. Recommendations for a public health approach. 2006,"},{"key":"168_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1086\/427192","volume":"191","author":"PR Harrigan","year":"2005","unstructured":"Harrigan PR, Hogg RS, Dong WW: Predictors of HIV drug resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005, 191: 339-47. 10.1086\/427192","journal-title":"J Infect Dis"},{"issue":"suppl 2","key":"168_CR4","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1086\/340197","volume":"185","author":"BJ Turner","year":"2002","unstructured":"Turner BJ: Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. J Infect Dis. 2002, 185 (suppl 2): S143-51. 10.1086\/340197","journal-title":"J Infect Dis"},{"issue":"12","key":"168_CR5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/01.aids.0000180094.04652.3b","volume":"19","author":"CJ Gill","year":"2005","unstructured":"Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL: No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS. 2005, 19 (12): 1243-9. 10.1097\/01.aids.0000180094.04652.3b","journal-title":"AIDS"},{"key":"168_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","volume":"133","author":"DL Paterson","year":"2000","unstructured":"Paterson DL, Swindells S, Mohr J, Brester M, Vergis E, Squire C: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000, 133: 21-30.","journal-title":"Ann Intern Med"},{"key":"168_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(01)05551-9","volume":"358","author":"AD Harries","year":"2001","unstructured":"Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM: Preventing antiretroviral anarchy in Africa. Lancet. 2001, 358: 410-4. 10.1016\/S0140-6736(01)05551-9","journal-title":"Lancet"},{"key":"168_CR8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1086\/520443","volume":"29","author":"N Singh","year":"1999","unstructured":"Singh N, Berman SM, Swindells S: Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999, 29: 824-30. 10.1086\/520443","journal-title":"Clin Infect Dis"},{"key":"168_CR9","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/00002030-199906180-00014","volume":"13","author":"RH Haubrich","year":"1999","unstructured":"Haubrich RH, Little SJ, Currier JS: The value of patient reported adherence to antiretroviral therapy in predicting virologic and immunologic response: California Collaborative Treatment Group. AIDS. 1999, 13: 1099-1107. 10.1097\/00002030-199906180-00014","journal-title":"AIDS"},{"key":"168_CR10","first-page":"I","volume-title":"38th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1998","author":"DL Paterson","year":"1998","unstructured":"Paterson DL, Swindels S, Mohr JA: Adherence with proteaseinhibitor therapy for human immunodeficiency virus infection. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1998. 1998, I-172. San Diego, California: American Society for Microbiology,"},{"key":"168_CR11","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1097\/00002030-199817000-00011","volume":"12","author":"H Kastrissios","year":"1998","unstructured":"Kastrissios H, Sua\u00e1rez J-R, Katzenstein D, Girard P, Sheiner LB, Blaschke TF: Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial. AIDS. 1998, 12: 2295-2303. 10.1097\/00002030-199817000-00011","journal-title":"AIDS"},{"key":"168_CR12","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJM199810293391801","volume":"339","author":"DV Havlir","year":"1998","unstructured":"Havlir DV, Marschner IC, Hirsch MS: Maintenance antiretroviral therapies in HIV infected patients with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team. N Engl J Med. 1998, 339: 1261-8. 10.1056\/NEJM199810293391801","journal-title":"N Engl J Med"},{"issue":"18","key":"168_CR13","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1056\/NEJM199810293391802","volume":"339","author":"G Pialoux","year":"1998","unstructured":"Pialoux G, Raffi F, Brun-Vezinet F, Meiffr\u00e9dy V, Flandre P, Gastaut JA, Dellamonica P, Yeni P, Delfraissy JF, Aboulker JP: A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Tril\u00e8ge (Agence Nationale de Recherches sur le SIDA 072) Study Team. N Engl J Med. 1998, 339 (18): 1269-76. 10.1056\/NEJM199810293391802","journal-title":"N Engl J Med"},{"key":"168_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0140-6736(98)06193-5","volume":"352","author":"MH Reijers","year":"1998","unstructured":"Reijers MH, Weverling GJ, Jurriaans S: Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study. Lancet. 1998, 352: 185-90. 10.1016\/S0140-6736(98)06193-5","journal-title":"Lancet"},{"key":"168_CR15","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1001\/jama.279.12.930","volume":"279","author":"JS Montaner","year":"1998","unstructured":"Montaner JS, Reiss P, Cooper D: A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study. JAMA. 1998, 279: 930-7. 10.1001\/jama.279.12.930","journal-title":"JAMA"},{"key":"168_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJM199807303390504","volume":"339","author":"FM Hecht","year":"1998","unstructured":"Hecht FM, Grant RM, Petropoulos CJ: Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med. 1998, 339: 307-11. 10.1056\/NEJM199807303390504","journal-title":"N Engl J Med"},{"key":"168_CR17","doi-asserted-by":"publisher","first-page":"906","DOI":"10.7326\/0003-4819-128-11-199806010-00008","volume":"128","author":"RW Shafer","year":"1998","unstructured":"Shafer RW, Winters MA, Palmer S, Merigan TC: Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients. Ann Intern Med. 1998, 128: 906-11.","journal-title":"Ann Intern Med"},{"issue":"4","key":"168_CR18","doi-asserted-by":"publisher","first-page":"e1000056","DOI":"10.1371\/journal.pmed.1000056","volume":"6","author":"Y Assefa","year":"2009","unstructured":"Assefa Y, Jerene D, Lulseged S, Ooms G, Van Damme W: Rapid scale-up of antiretroviral treatment in Ethiopia: successes and system-wide effects. PLoS Med. 2009, 6 (4): e1000056- 10.1371\/journal.pmed.1000056","journal-title":"PLoS Med"},{"key":"168_CR19","volume-title":"Guideline for Implementation of Antiretroviral Therapy in Ethiopia, Addis Ababa Ethiopia","author":"Ministry of Health of Ethiopia","year":"2005","unstructured":"Ministry of Health of Ethiopia: Guideline for Implementation of Antiretroviral Therapy in Ethiopia, Addis Ababa Ethiopia. 2005,"},{"issue":"5","key":"168_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJM199807303390504","volume":"339","author":"FM Hecht","year":"1998","unstructured":"Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MA, Tian H, Hellmann NS, Bandrapalli NI, Digilio L, Branson B, Kahn JO: Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med. 1998, 339 (5): 307-11. 10.1056\/NEJM199807303390504","journal-title":"N Engl J Med"},{"key":"168_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/1471-2458-8-265","volume":"8","author":"A Amberbir","year":"2008","unstructured":"Amberbir A, Woldemichael K, Getachew S: Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia. BMC Public Health. 2008, 8: 265- 10.1186\/1471-2458-8-265","journal-title":"BMC Public Health"},{"issue":"5","key":"168_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/QAI.0b013e318165dc25","volume":"47","author":"JG Carlucci","year":"2008","unstructured":"Carlucci JG, Kamanga A, Sheneberger R, Shepherd BE, Jenkins CA, Spurrier J, Vermund SH: Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr. 2008, 47 (5): 615-22. 10.1097\/QAI.0b013e318165dc25","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"168_CR23","first-page":"237","volume":"44","author":"Y Tadios","year":"2006","unstructured":"Tadios Y, Davey G: Antiretroviral treatment adherence and its correlates among people living with HIV\/AIDS on highly active antiretroviral therapy in Addis Ababa, Ethiopia. EMJ. 2006, 44 (2): 237-244.","journal-title":"EMJ"},{"issue":"2","key":"168_CR24","first-page":"174","volume":"22","author":"E Markos","year":"2008","unstructured":"Markos E, Worku A, Davey G: Adherence to ART in PLWHA at Yirgalem Hospital, South Ethiopia Ethiop. J Health Dev. 2008, 22 (2): 174-179.","journal-title":"J Health Dev"},{"key":"168_CR25","volume-title":"AAU; MPH Thesis","author":"A Mengesha","year":"2005","unstructured":"Mengesha A, Worku A: Assessment of antiretroviral treatment among HIV infected persons in the Ministry of Defense Hospitals. AAU; MPH Thesis. 2005,"},{"issue":"suppl 2","key":"168_CR26","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1086\/313849","volume":"30","author":"MA Chesney","year":"2000","unstructured":"Chesney MA: Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000, 30 (suppl 2): S171-S176. 10.1086\/313849","journal-title":"Clin Infect Dis"},{"key":"168_CR27","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1001\/archinte.161.16.1962","volume":"161","author":"PT Nieuwkerk","year":"2001","unstructured":"Nieuwkerk PT, Sprangers MA, Burger DM: Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med. 2001, 161: 1962-1968. 10.1001\/archinte.161.16.1962","journal-title":"Arch Intern Med"},{"key":"168_CR28","volume-title":"6th Conference on Retroviruses and Opportunistic Infections, Chicago","author":"N Wegner","year":"1999","unstructured":"Wegner N, Gifford A, Liu H: Patient characteristics and attitudes associated with antiretroviral adherence. 6th Conference on Retroviruses and Opportunistic Infections, Chicago. 1999,"},{"key":"168_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00126334-200311010-00004","volume":"34","author":"S Weiser","year":"2003","unstructured":"Weiser S, Bangsberg D: Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003, 34: 281-288. 10.1097\/00126334-200311010-00004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"168_CR30","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1097\/00002030-200306130-00011","volume":"17","author":"C Orrell","year":"2003","unstructured":"Orrell C, Bangsberg DR, Badri M: Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. 2003, 17: 1369-1375. 10.1097\/00002030-200306130-00011","journal-title":"AIDS"},{"issue":"4","key":"168_CR31","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/sj.ejcn.1601853","volume":"58","author":"LE Torheim","year":"2004","unstructured":"Torheim LE, Ouattara F, Diarra MM, Thiam FD, Barikmo I, Hatl\u00f8y A, Oshaug A: Nutrient adequacy and dietary diversity in rural Mali: association and determinants. Eur J Clin Nutr. 2004, 58 (4): 594-604. 10.1038\/sj.ejcn.1601853","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"168_CR32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/09540120500456631","volume":"18","author":"LN Schonnesson","year":"2006","unstructured":"Schonnesson LN, Diamond WPM, Michael Ross: Baseline predictors of three types of antiretroviral therapy (ART) adherence: A 2-year follow-up. AIDS Care. 2006, 18 (3): 246-253.","journal-title":"AIDS Care"},{"issue":"suppl 4","key":"168_CR33","doi-asserted-by":"publisher","first-page":"s5","DOI":"10.1097\/01.aids.0000191484.84661.2b","volume":"19","author":"PF Bonolo","year":"2005","unstructured":"Bonolo PF, C\u00e9sar CC, Acurcio FA: Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil. AIDS. 2005, 19 (suppl 4): s5-s13. 10.1097\/01.aids.0000191484.84661.2b","journal-title":"AIDS"},{"issue":"5","key":"168_CR34","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/00126334-200004150-00005","volume":"23","author":"AL Gifford","year":"2000","unstructured":"Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA: Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000, 23 (5): 386-95.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"168_CR35","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1089\/108729101753287685","volume":"11","author":"L Brigido","year":"2001","unstructured":"Brigido L, Rodrigues R, Casseb J, Oliveira D, Rossetti M: Impact of adherence to antiretroviral therapy in HIV-1-infected patients at a university public service in Brazil. AIDS Patient Care STDS. 2001, 11: 587-593. 10.1089\/108729101753287685.","journal-title":"AIDS Patient Care STDS"},{"key":"168_CR36","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/0277-9536(91)90093-R","volume":"32","author":"EV Morse","year":"1991","unstructured":"Morse EV, Simon PM, Coburn M, Hyslop N, Greenspan D, Balson PM: Determinants of subject compliance within an experimental anti-HIV drug protocol. Soc Sci Med. 1991, 32: 1161-7. 10.1016\/0277-9536(91)90093-R","journal-title":"Soc Sci Med"},{"issue":"1","key":"168_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00126334-200101010-00012","volume":"26","author":"CA Kleeberger","year":"2001","unstructured":"Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP: Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001, 26 (1): 82-92.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"168_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/09540120050123783","volume":"12","author":"X Gao","year":"2000","unstructured":"Gao X, Nau DP, Rosenbluth SA: The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care. 2000, 12: 387-98. 10.1080\/09540120050123783","journal-title":"AIDS Care"},{"key":"168_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1742-6405-6-21","volume":"6","author":"M Rougemont","year":"2009","unstructured":"Rougemont M, Stoll BE, Elia N, Ngang P: Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon. AIDS Res Ther. 2009, 6: 21- 10.1186\/1742-6405-6-21","journal-title":"AIDS Res Ther"},{"key":"168_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1742-4690-5-13","volume":"5","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Zarkadoulia EA, Pliatsika PA, Panos G: Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature. Retrovirology. 2008, 5: 13- 10.1186\/1742-4690-5-13","journal-title":"Retrovirology"},{"issue":"10","key":"168_CR41","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/09540120701854634","volume":"20","author":"E Grant","year":"2008","unstructured":"Grant E, Logie D, Masura M, Gorman D, Murray SA: Factors facilitating and challenging access and adherence to antiretroviral therapy in a township in the Zambian Copper belt: a qualitative study. AIDS Care. 2008, 20 (10): 1155-60. 10.1080\/09540120701854634","journal-title":"AIDS Care"},{"key":"168_CR42","doi-asserted-by":"publisher","first-page":"385\/93","DOI":"10.1089\/1087291041518238","volume":"18","author":"GJ Wagner","year":"2004","unstructured":"Wagner GJ, Ryan GW: Relationship between routinization of daily behaviors and medication adherence in HIV-positive drug users. AIDS Patient Care STDS. 2004, 18: 385\/93-10.1089\/1087291041518238.","journal-title":"AIDS Patient Care STDS"},{"issue":"2","key":"168_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1037\/0278-6133.23.2.207","volume":"23","author":"MR DiMatteo","year":"2004","unstructured":"DiMatteo MR: Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004, 23 (2): 207-18. 10.1037\/0278-6133.23.2.207","journal-title":"Health Psychol"},{"issue":"5","key":"168_CR44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10461-006-9106-6","volume":"10","author":"MJ Stirratt","year":"2006","unstructured":"Stirratt MJ, Remien RH, Smith A, Copeland OQ, Dolezal C, Krieger D, SMART Couples Study Team: The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS Behav. 2006, 10 (5): 483-93. 10.1007\/s10461-006-9106-6","journal-title":"AIDS Behav"},{"issue":"7","key":"168_CR45","first-page":"51","volume":"9","author":"A Williams","year":"1997","unstructured":"Williams A, Friedland G: Adherence, compliance, and HAART. AIDS Clinical Care. 1997, 9 (7): 51-53.","journal-title":"AIDS Clinical Care"},{"key":"168_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/00042560-199808010-00005","volume":"18","author":"F Motashari","year":"1998","unstructured":"Motashari F: Acceptance and adherence with HAART therapy among HIV infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998, 18: 341-348.","journal-title":"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology"},{"key":"168_CR47","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/09540120410001683402","volume":"16","author":"DA Murphy","year":"2004","unstructured":"Murphy DA, Marelich WD, Hoffman D: Predictors of Antiretroviral Adherence. AIDS Care. 2004, 16: 471-484. 10.1080\/09540120410001683402","journal-title":"AIDS Care"},{"issue":"2","key":"168_CR48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1468-1293.2003.00147.x","volume":"4","author":"OW Fong","year":"2003","unstructured":"Fong OW, Ho CF, Fung LY, Lee FK, Tse WH, Yuen CY, Sin KP, Wong KH: Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV\/AIDS patients. HIV Med. 2003, 4 (2): 133-8. 10.1046\/j.1468-1293.2003.00147.x","journal-title":"HIV Med"},{"key":"168_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2431-8-34","volume":"8","author":"MA Davies","year":"2008","unstructured":"Davies MA, Boulle A, Fakir T, Nuttall J, Eley B: Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr. 2008, 8: 34- 10.1186\/1471-2431-8-34","journal-title":"BMC Pediatr"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-6405-7-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:25:05Z","timestamp":1630470305000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/1742-6405-7-39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,30]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1186\/1742-6405-7-39","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,30]]},"assertion":[{"value":"26 June 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"39"}}